Skip to main content

Want a detailed portfolio tracker?

MeiraGTx (MGTX) P/E (2018 - 2026)

MeiraGTx (MGTX) P/E from Jul 2, 2018 to Jul 21, 2026. The TTM MeiraGTx (MGTX) P/E is -8.39. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of MeiraGTx (MGTX)

YearP/EChange
2026-8.39+50.61%
2025-5.57+90.10%
2024-2.93+1.42%
2023-2.89+11.23%
2022-2.60-80.37%
2021-13.23+31.97%
2020-10.02-19.96%
2019-12.52+216.86%
2018-3.95N/A

Comparison MeiraGTx (MGTX) P/E with competitors

MeiraGTx (MGTX) P/E is -8.39.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.89%
FGENFibroGen Inc0.24-102.86%
CHRSCoherus Biosciences Inc0.85-110.11%
FBIOFortress Biotech Inc0.95-111.31%
ORMPOramed Pharmaceuticals Inc1.50-117.92%
AGENAgenus Inc3.01-135.87%
INVAInnoviva Inc3.15-137.59%
VXRTVaxart Inc3.55-142.31%
CRMDCorMedix Inc3.63-143.25%
CVACCureVac N.V.4.45-152.99%
GLPGGalapagos NV4.86-157.92%
SRPTSarepta Therapeutics Inc4.88-158.19%
ABEOAbeona Therapeutics Inc5.39-164.22%
ABUSArbutus Biopharma Corp5.60-166.70%
ZVRAZevra Therapeutics Inc5.89-170.17%
SPROSpero Therapeutics Inc6.23-174.24%
CGENCompugen Ltd6.31-175.26%
RIGLRigel Pharmaceuticals6.87-181.91%
SLXNSilexion Therapeutics Corp7.30-186.97%
OMEROmeros Corporation9.26-210.36%
AUPHAurinia Pharmaceuticals Inc9.58-214.25%
PLXProtalix BioTherapeutics Inc10.89-229.82%
ACADAcadia Pharmaceuticals Inc11.73-239.80%
TBPHTheravance Biopharma Inc12.26-246.16%
ADMAAdma Biologics Inc12.42-248.02%
HRMYHarmony Biosciences Holdings Inc13.82-264.73%
SABSSAB Biotherapeutics Inc14.14-268.50%
NAGENiagen Bioscience Inc14.82-276.62%
INCYIncyte Corp15.82-288.60%
REGNRegeneron Pharmaceuticals Inc15.86-289.00%
PBYIPuma Biotechnology Inc17.32-306.39%
CPRXCatalyst Pharmaceuticals Inc17.44-307.87%
EXELExelixis Inc17.54-309.04%
TGTXTG Therapeutics Inc18.97-326.07%
MDXGMimedx Group Inc20.55-344.98%
XOMAXOMA Royalty Corp22.87-372.66%
ARGXArgen X SE24.30-389.63%
CTMXCytomX Therapeutics Inc24.82-395.86%
XOMAOXOMA Royalty Corp25.34-402.11%
HALOHalozyme Therapeutics Inc25.62-405.43%
XOMAPXOMA Royalty Corp25.67-405.98%
VRTXVertex Pharmaceuticals Inc27.99-433.69%
RPRXRoyalty Pharma plc - Class A28.69-441.95%
SLNOSoleno Therapeutics Inc29.02-445.86%
ASNDAscendis Pharma A/S30.09-458.61%
LGNDLigand Pharmaceuticals Inc - Class B37.91-551.90%
APLSApellis Pharmaceuticals Inc39.02-565.13%
BMRNBiomarin Pharmaceutical Inc42.21-603.16%
KRYSKrystal Biotech Inc45.34-640.49%
ONCBeiGene Ltd69.54-928.91%
PHARPharming Group N.V.75.03-994.29%
TECHBio-Techne Corp101.96-1315.33%
VCELVericel Corp109.92-1410.24%
ALNYAlnylam Pharmaceuticals Inc117.96-1506.12%
GMABGenmab140.29-1772.24%
TLXTelix Pharmaceuticals Ltd162.15-2032.84%
CORTCorcept Therapeutics Inc212.86-2637.23%